The management of human papillomavirus (HPV)-positive oropharyngeal cancer is shifting as oncologists balance high cure rates ...
A team of scientists at Henry Ford Health + Michigan State University Health Sciences have uncovered a mechanism that allows ...
November 6, 2008 — Human papillomavirus (HPV) infection has recently been established as an important risk factor for oropharyngeal cancers. Using a noninvasive oral rinse, researchers have now ...
Researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove ...
Short-interval HPV retesting showed promise for identifying high-risk cervical neoplasia in HPV-positive patients. A positive repeat HPV test at 2 months had 82-88% sensitivity for high-grade cervical ...
February 17, 2010 – It is well established that patients with squamous cell carcinoma of the oropharynx that tests positive for human papillomavirus (HPV) have a more favorable outcome and are more ...
Data shows Versamune® HPV may effectively treat HPV16-associated cancers; Phase 3 trial in head and neck cancer starts Q1 2025. PDS Biotechnology Corporation announced promising data for its lead ...
Median Overall Survival (mOS) of 42.4 months in immune checkpoint inhibitor naïve patients; Historical published result is 7-12 months Continued survival in the cohort of HPV16-positive immune ...
PARIS--(BUSINESS WIRE)--LinKinVax, a clinical-stage biotechnology company focusing on innovative protein-based vaccines, and Gustave Roussy, the leading cancer centre in Europe ranked third Best ...
Usually, pap smears are performed at a clinic by a doctor or healthcare provider, but with the new kits, patients will have the option of collecting their own sample on site, or taking a kit home, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results